REMIT DR CAP 30MG CAP

by Scotman
Rs.500.00


Rs. 13.00 per
30 s per pack
Bank Cards
Remit Dr Capsules 30mg Cap is composed of
Belongs to the category
Acidity & Ulcers

Uses
REMIT DR is a proton pump inhibitor (PPI) indicated for: Healing of all grades of erosive esophagitis (EE), Maintaining healing of EE and relief of heartburn,  Treating heartburn associated with symptomatic non-erosive gastroesophageal reflux disease (GERD).

Side Effects

The following serious adverse reactions are described below: Acute Interstitial Nephritis, Cyanocobalamin (Vitamin B-12) Deficiency, Clostridium difficile Associated Diarrhea, Bone Fracture, Hypomagnesemia


When not to use

It should not be used in patients with In patients with known hypersensitivity to any component of the formulation, Hypersensitivity reactions, including anaphylaxis.  


Precaution
Presence of Gastric Malignancy: Symptomatic response with Remit does not preclude the presence of gastric malignancy.

Precaution

Acute Interstitial Nephritis: Acute interstitial nephritis is observed in patients taking PPIs including lansoprazole. Acute interstitial nephritis may occur at any point during PPI therapy and is generally attributed to an idiopathic hypersensitivity reaction. Discontinue Remit if acute interstitial nephritis develops.


Precaution

Cyanocobalamin (Vitamin B-12) Deficiency: Daily treatment with any acid-suppressing medications over a long period of time (e.g., longer than 3 years) may lead to malabsorption of cyanocobalamin (Vitamin B-12) caused by hypo- or achlorhydria. 


Precaution
Keep all medicines out of the reach and sight of children. Store in a cool, dry place, away from direct heat and light.

Pregnancy

This Medicine should not be use in Pregnancy.


Drugs to avoid

Atazanavir: Do not co-administer with REMIT DR because atazanavir systemic concentrations may be substantially decreased. Drugs with pH-dependent absorption (e.g., ampicillin esters, digoxin, iron salts, ketoconazole, erlotinib, mycophenolate mofetil): REMIT DR may interfere with absorption of drugs for which gastric pH is important for bioavailability.
Warfarin: Patients taking concomitant warfarin may require monitoring for increases in international normalized ratio (INR) and prothrombin time.
Tacrolimus: Concomitant tacrolimus use may increase tacrolimus whole blood concentrations. Methotrexate: REMIT DR may increase serum levels of methotrexate.


You recently viewed

Clear recently viewed